期刊文献+

清热养阴活血法对糖尿病大鼠肾脏VEGF表达的影响 被引量:1

Effect of Chinese Herb for Clearing Heat Nourishing Yin and Activating Blood on the Expression of Vascular Endothelial Growth Factor in Kidney of Diabetic Rats
下载PDF
导出
摘要 目的:观察清热养阴活血方剂逐瘀化消饮对DM大鼠肾脏VEGF表达的影响。方法:采用β-cyto-toxins大鼠模型,将Wistar大鼠随机分为正常组、模型组、胰岛素组、逐瘀化消饮低、中、高剂量+胰岛素组,观察糖尿病大鼠在胰岛素控制血糖基本一致的情况下,逐瘀化消饮治疗八周,用免疫组化方法检测DM大鼠肾脏组织中VEGF的分布状况。结果:与胰岛素组相比,逐瘀化消饮能抑制DM大鼠肾脏VEGF的表达。结论:逐瘀化消饮通过多种机制抑制DM大鼠肾脏VEGF表达,这可能是其防治DM大鼠肾脏微血管病变发生发展的机理之一。 Objective:To observe the effect on the expression of Vascular endothelial growth factor in kidney of diabetic rats by clearing heat,nourishing yin and activating blood.Methods:Imitated the model rats of diabetes mellitus(DM) induced by β-cytotoxins. Apart from the control groups,all the model rats were divided into five groups at random,namely the pathology group,Insulin group,the low dose ZYHXY and insulin group(ZYHXY-L),the middle dose ZYHXY and insulin group(ZYHXY-M),the high dose ZYHXY and insulin group(ZYHXY-H). On the condition all the model rats had the same blood glucose controlled by insulin,observe the effect on the expression of VEGF in kidney after treated eight weeks by ZYHXY.Results:In comparing with the insulin groups,the low,middle,high dose groups of ZYHXY have the significant difference(P0.05),in inhibiting the expression of VEGF in kidney.Conclusion:ZYHXY can inhibit the experession of VEGF in kidney,which is probably the one of the mechanism of treatment and prevention the diabetic angiopathy.
作者 戴红
出处 《中华中医药学刊》 CAS 2010年第8期1693-1695,共3页 Chinese Archives of Traditional Chinese Medicine
基金 湖北中医学院科研课题(2004)
关键词 糖尿病 血管病变 实验研究 血管内皮生长因子 逐瘀化消饮 diabetes mellitus laboratary study vascular endothelial growth factor(VEGF) Zhuyu Huaxiao Yin(ZYHXY)
  • 相关文献

参考文献15

  • 1钱荣立等主编..21世纪的糖尿病防治[M].郑州:河南医科大学出版社,2000:476.
  • 2Wasada T,Katsumori K, et al. Plasma concentration of immuaoreactive vascular endothelial growth factor and its relation to smoking[ J ]. Metabolism, 1998,47 ( 1 ) :27 - 30. 被引量:1
  • 3Nishizuka Y. lntracellular signaling by hydrolysis of phospholipids and activation of protein kinasc C [ J ]. Science, 1992,258 : 607. 被引量:1
  • 4Brown L F, Detmar M, Cla.ffey K, et al. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine[ J]. EXS, 1997,79:233 - 269. 被引量:1
  • 5Unemori EN, Ferrara N, Bauer EA, et al. Vascular endothelial growth factor induce interstitial collagenase expression in human endothelial cell[J]. J Cell Physiol,1992,153(3) :557 -562. 被引量:1
  • 6林辉.血管内皮生长因子与糖尿病肾病[J].国外医学(内分泌学分册),2002,22(3):186-188. 被引量:7
  • 7Esser S, Wolburg K, Wolburg H, et al. Vascular endothelial growth factor induces endothelial fenestration in vivo[ J]. J Cell Biol, 1998,140:947 - 959. 被引量:1
  • 8Amemiya T, Sasamura H, Mifune M, et al. Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells [ J]. Kindey Int, 1999,56: 2055 - 2063. 被引量:1
  • 9Stephan C C,Chang K C,Leijeune W,et al. Role for heparin - binding growth factors in glucose - induced vascular dysfunction [ J]. Diabetes, 1998,47 : 1771 - 1778. 被引量:1
  • 10Satchell SC, Mathieson PW. Angiopoietins : microvascular modulators with potential roles in glomerular pathophysiology[ J]. J Nephrol,2003,16 : 168 - 178. 被引量:1

二级参考文献24

  • 1Nishizuka Y. lntracellular signaling by hydrolysis of phospholipids and activation of protein kinase C[J ]. Science, 1992,258: 607 被引量:1
  • 2King GL, Banskota NK. Mechanisma of diabetic vascular complications [ M ]. NewYork: Oxford University Press,1994. 631 被引量:1
  • 3De Rubertis FR, Craven PA. Activation of protein kinase C in glomerular cells in diabetes[J]. Diabetes, 1994, 43:1 被引量:1
  • 4King GL. Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus [ J ]. Annu Rev Med,1994, 45:179 被引量:1
  • 5Inoguchi T. Insulin's effect on protein kinase C and diacyglycerol induced by diabetes and glucose in vascular tissues[J]. Am J Physiol, 1994,267: 369 被引量:1
  • 6Thomas S, Vanuystel J, Gruden G, et al. Vascular endothelial growt h factor receptors in human mesangium in vitro and in glomerular disease[J]. J Am Soc Nephol,2000,11:1236-1243. 被引量:1
  • 7Shulman K, Rosen S, Tognazzi K, et al. Expression of vascula r permeability factor (VPF/VEGF) is altered in many glomerular diseases[J].J Am Soc Nephol,1996,7:661-666. 被引量:1
  • 8Cooper M E, Vranes D, Youssef S, et al. Increased renal exp ression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental di abetes[J].Diabetes,1999,48:2229-2239. 被引量:1
  • 9Cha D R, Kim N H, Yoon J W, et al. Role of vascular endothel ial growth factor in diabetic nephropathy[J].Kidney Int,2000,58 (Suppl 77):S104-S 112. 被引量:1
  • 10Antonetti D A, Barber A J, Khin S, et al. Vascular permeabil ity in experim ental diabetes is associated with reduced endothelial cells. Penn State Retina Research Group[J].Diabetes,1998,47:1953-1959. 被引量:1

共引文献326

同被引文献16

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部